Cipla receives USFDA nod to market Lanreotide injection in US market | Business Standard News

Quote










































Lots of buyers remorse for those here that bought those discounted ipsen shares a few months ago. That discount you can get now every day and flip the stock when you need to. Might as well make lemonade out of lemons. The board was so clever to fool so many people here to buy the stock with a 5yr lock before selling.
 






anonymous said:
Lots of buyers remorse for those here that bought those discounted ipsen shares a few months ago. That discount you can get now every day and flip the stock when you need to. Might as well make lemonade out of lemons. The board was so clever to fool so many people here to buy the stock with a 5yr lock before selling.
Click to expand...

Unfortunately, the stock is going to be dead money for the foreseeable future. Look at the so-called leadership in this place.
 






anonymous said:
Lots of buyers remorse for those here that bought those discounted ipsen shares a few months ago. That discount you can get now every day and flip the stock when you need to. Might as well make lemonade out of lemons. The board was so clever to fool so many people here to buy the stock with a 5yr lock before selling.
Click to expand...

Well, that’s what you get for trusting the conniving, malodorous French.
 


















Top Bottom
Back
Quote